3 Blue Cross Illinois Updates- Major Drug Card Changes, Free October 23rd Webinar on the NEW Wellness Program and Lost HMO Doctors

1. October 17, 2012
October Worksite Webinar Invitation: Overview of New Well onTargetSM Wellness Tools
You are invited to attend a Worksite Wellness Webinar, hosted by Live Meeting.
On Jan. 1, 2013, BCBSIL is launching Well onTargetSM. This innovative and affordable new wellness solution
offers an expanded array of highly personalized tools and resources to help you increase employee
participation and enrich your company's wellness culture.
When: Tuesday, Oct. 23, 10:00 a.m. Central Time (1 hour)
What: Join this online forum about workplace wellness for employer groups. This series of one-hour webinars
will provide employer groups with tools you can use to help improve employee productivity and well-being.
Who: The moderator for this webinar is Cheryl Pollard, CHES, Sr. Wellness Consultant at Blue Cross and
Blue Shield of Illinois (BCBSIL). In her current role, primary responsibilities include consulting with clients to
promote understanding of the integrated suite of Blue Cross and Blue Shield wellness program offerings,
promoting engagement and participation in the wellness programs, and, ultimately, assisting clients to achieve
a wellness culture within their work environment. Cheryl has been with BCBSIL for more than two years and
has 10-plus years of experience in wellness consultation and employer-based health improvement programs.
Where: Via a webinar, hosted by LiveMeeting.
How to join: To join the Worksite Wellness Webinar, please use the website address below:
https://www.livemeeting.com/cc/hcsc/join?id=79WMMQ&role=attend
After logging in, you will receive further instructions for participating in the webinar.
Below is information that you will need if you are having difficulty joining the webinar with the link above:
Meeting URL: https://www.livemeeting.com/cc/bcbsil/join
Meeting ID: 79WMMQ
Also, we are providing a toll-free Audio Conferencing dial-in number:
Audio Conferencing (Toll-free): 877- 440 - 4272
Confirmation Number: 5571 734#
After entering your passcode, you will be prompted to provide your name after the tone. This information is
required to participate in a Question and Answer session at any time during the conference call.
First-time users: To save time before the meeting, check your system to make sure it is compatible with
Microsoft Office Live Meeting: http://go.microsoft.com/fwlink/?LinkId=90703
Did you miss our September wellness webinar featuring a wellness program case study? View the highlights.
JEFF PETRO VP INSURANCE SALES ADVISER INDUSTRIAL INSURANCE 847.485.2202

2. October 17, 2012
Pharmacy Program Changes Effective Jan. 1, 2013
Standard Formulary Changes
Based on Prime's National Pharmacy and Therapeutics Committee's review of changes in the
pharmaceuticals market, some revisions will be made to the standard Blue Cross and Blue Shield of Illinois
(BCBSIL) formulary effective Jan. 1, 2013.
Brand Medications Moving to a Higher Out-of-Pocket Payment Level
Effective Jan. 1, 2013
Non-Formulary Condition Generic Formulary Brand
Brand1 Used For Formulary Alternative(s)2 Alternative(s)1,2
Diovan High Blood Pressure irbesartan, losartan, valsartan Benicar
irbesartan/HCTZ, losartan/HCTZ,
Diovan HCT High Blood Pressure Benicar HCT
valsartan/HCTZ
Testim Low Testosterone N/A Androderm, Androgel
N/A = not applicable
1
Third-party brand names are the property of their respective owners.
2
This list is not all-inclusive. Other medications may be available in this drug class.
Targeted mailings were sent to members affected by formulary changes per our usual process of notifying
members at least 60 days prior to implementation.
Standard Formulary Dispensing Limit Changes
BCBSIL's standard prescription drug benefit program includes coverage limits on certain medications and
drug categories. Dispensing limits are based on FDA-approved dosage regimens and product labeling.
Effective Jan. 1, 2013, dispensing limits will be added for the following drugs:
Drug Class and Medication* Dispensing Limit
COPD
Arcapta Neohaler (indacaterol) 1 box (30 doses)/Rx
Hereditary Angioedema
Firazyr (icatibant) 3 syringes/Rx
Hyperactivity
Adderall 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg, 30 mg 60 tabs/30 days
(amphetamine/dextroamphetamine)
Adderall 20 mg (amphetamine/dextroamphetamine) 90 tabs/30 days
Adderall XR (amphetamine/dextroamphetamine ext-release) 30 caps/30 days
Concerta 18 mg, 27 mg, 54 mg (methylphenidate ext-release) 30 tabs/30 days
Concerta 36 mg (methylphenidate ext-release) 60 tabs/30 days
Daytrana (methylphenidate transdermal patch) 30 patches/30 days
dextroamphetamine 5 mg 60 tabs/30 days
dextroamphetamine 10 mg 180 tabs/30 days
JEFF PETRO VP INSURANCE SALES ADVISER INDUSTRIAL INSURANCE 847.485.2202

3. Dexedrine 5 mg (dextroamphetamine ext-release) 90 caps/30 days
Dexedrine 10 mg, 15 mg (dextroamphetamine ext-release) 120 caps/30 days
Desoxyn 5 mg (methamphetamine) 150 tabs/30 days
Focalin (dexmethylphenidate) 60 tabs/30 days
Focalin XR (dexmethylphenidate ext-release) 30 caps/30 days
Drug Class and Medication* Dispensing Limit
Intuniv (guanfacine ext-release) 30 tabs/30 days
Kapvay 0.1 mg (clonidine ext-release) 120 tabs/30 days
Kapvay 0.2 mg (clonidine ext-release) 60 tabs/30 days
Metadate ER 10 mg, 20 mg (methylphenidate ext-release) 90 tabs/30 days
Metadate CD (methylphenidate ext-release) 30 caps/30 days
Methylin 2.5 mg chewable, 5 mg chewable (methylphenidate) 90 tabs/30 days
Methylin 10 mg chewable (methylphenidate) 180 tabs/30 days
Methylin 5 mg/5 ml (methylphenidate) 450 ml/30 days
Methylin 10 mg/5 ml (methylphenidate) 900 ml/30 days
Methylin ER 10 mg, 20 mg (methylphenidate ext-release) 90 tabs/30 days
Procentra 5 mg/5 ml (dextroamphetamine) 1,800 ml/30 days
Ritalin (methylphenidate) 90 tabs/30 days
Ritalin LA 10 mg, 20 mg, 40 mg (methylphenidate ext-release) 30 caps/30 days
Ritalin LA 30 mg (methylphenidate ext-release) 60 caps/30 days
Ritalin SR 20 mg (methylphenidate ext-release) 90 tabs/30 days
Straterra 10 mg, 18 mg, 25 mg, 40 mg, 60 mg (atomoxetine) 60 caps/30 days
Straterra 80 mg, 100 mg (atomoxetine) 30 caps/30 days
Vyvanse (lisdexamfetamine) 30 caps/30 days
Male Hormones
Androderm 2 mg (testosterone) 30 patches/30 days
Androgel 1.62% (testosterone) 2 bottles/30 days
Axiron (testosterone) 2 bottles/30 days
Delatestryl 100mg/ml, 200 mg/ml; 10 ml vial (testosterone) 1 vial/28 days
Delatestryl 200 mg/ml; 1 ml vial (testosterone) 4 vials/28 days
First-Testosterone ointment, cream (testosterone) 60 grams/30 days
Fortesta (testosterone) 2 bottles/30 days
Striant (testosterone) 2 buccal systems/30 days
Nasal Products
Qnasl (beclomethasone diproprionate) 1 bottle/30 days
Zetonna (ciclesonide) 1 canister/30 days
Dymista (azelastine/fluticasone) 1 bottle/30 days
Neuromuscular Drugs
Gralise 300 mg (gabapentin ext-release) 30 tabs/30 days
Gralise 600 mg (gabapentin ext-release) 90 tabs/30 days
Gralise Starter Pack (gabapentin ext-release) 1 pack/30 days
Horizant (gabapentin enacarbil) 30 tabs/30 days
* Third-party brand names are the property of their respective owners.
Review the most up-to-date list of drug dispensing limits.
Targeted mailings were sent to members affected by changes in dispensing limits per our usual
process of notifying members at least 60 days prior to implementation.
If you have questions regarding these changes, please contact PPO (800) 541-2768 HMO (800) 892-2803
JEFF PETRO VP INSURANCE SALES ADVISER INDUSTRIAL INSURANCE 847.485.2202

4. October 17, 2012
HMO Network Update: Tri County Physicians Association HMO Contract Terminated
It is unfortunate that we must inform you that Tri County Physicians Association has officially terminated
BOTH its HMO Illinois and BlueAdvantageSM HMO agreements. It is important to note that this development
affects HMO members only, and only services provided by Tri County Physicians Association. This does not
affect our PPO members or contracts.
The termination will become effective Jan. 1, 2013, and will impact approximately 3,200 HMO members
currently with Tri County Physicians Association. We will begin notifying our group administrators and
members this week.
Members will be given the opportunity to select new medical groups. Most of the doctors with Tri County
Physicians Association are affiliated with another network medical group, which means most members will be
able to keep their current doctor. Our transition of care plan will also be put into place so we can ensure that
members' treatment will not be negatively impacted and that we have appropriate time to transfer membership
to other groups.
Members who have questions should call HMO (800) 892-2803
JEFF PETRO VP INSURANCE SALES ADVISER INDUSTRIAL INSURANCE 847.485.2202